A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis

From National Research Council Canada

Alternative titleSARS-CoV-2 and COVID-19 in Canada
  1. (PDF, 3 MB)
  2. (PDF, 1 MB)
DOIResolve DOI: https://doi.org/10.1139/bcb-2020-0341
AuthorSearch for: 1; Search for: 1; Search for: 2; Search for: 1
Name affiliation
  1. National Research Council of Canada. Nanotechnology
  2. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Journal titleBiochemistry and Cell Biology
Article numberbcb-2020-0341
Physical description75 p.
SubjectCanada; COVID-19; coronavirus; inflammation; therapeutics; chronic disease
Publication date
PublisherCanadian Science Publishing
In pressYes
Peer reviewedYes
NRC numberNRC-NANO-80
Export citationExport as RIS
Report a correctionReport a correction
Record identifier722b7ea8-6534-4c92-9e43-e1af880e59ba
Record created2021-01-27
Record modified2021-04-06
Date modified: